Financial Results Approval

The Board approved the unaudited financial results for Q2 FY27 (quarter ended September 30, 2026) and the Limited Review Report from statutory auditors ASA & Associates LLP. The financial results were signed by Mr. Nithiyanandam Anandkumar, Non-Executive, Non-Independent Director.

Key Financial Figures (₹ in Lakhs)

Quarterly Performance (Q2 FY27 vs Q2 FY26)

  • Total Income: ₹33,407.75 (vs ₹21,707.22 in Q2 FY26)
  • Total Expenses: ₹30,715.24 (vs ₹20,514.63 in Q2 FY26)
  • Profit Before Tax: ₹2,692.51 (vs ₹1,192.59 in Q2 FY26)
  • Tax Expense: ₹674.70 (includes current tax ₹875.91, earlier years credit ₹(92.20), deferred tax credit ₹(109.01))
  • Net Profit: ₹2,017.81 (vs ₹888.73 in Q2 FY26)
  • EPS (Basic & Diluted): ₹11.29 (vs ₹4.97 in Q2 FY26)

Half-Yearly Performance (H1 FY27 vs H1 FY26)

  • Total Income: ₹55,114.97 (vs ₹48,365.03 in H1 FY26)
  • Total Expenses: ₹51,229.87 (vs ₹45,225.24 in H1 FY26)
  • Profit Before Tax: ₹3,885.10 (vs ₹3,139.79 in H1 FY26)
  • Tax Expense: ₹978.56 (includes current tax ₹1,170.25, earlier years credit ₹(92.20), deferred tax credit ₹(99.49))
  • Net Profit: ₹2,906.54 (vs ₹2,343.03 in H1 FY26)
  • EPS (Basic & Diluted): ₹16.26 (vs ₹13.10 in H1 FY26)

Balance Sheet Position (as of September 30, 2026)

  • Total Assets: ₹63,721.16 lakhs (vs ₹55,922.16 lakhs as of March 31, 2026)
  • Current Assets: ₹47,625.45 lakhs (includes Inventories ₹19,746.17 lakhs, Trade Receivables ₹15,925.61 lakhs)
  • Non-Current Assets: ₹16,095.71 lakhs
  • Total Equity: ₹40,019.98 lakhs (Equity Share Capital: ₹1,787.96 lakhs, Other Equity: ₹38,232.02 lakhs)
  • Current Liabilities: ₹22,987.11 lakhs (includes Trade Payables: ₹13,863.69 lakhs)

Cash Flow Statement (H1 FY27)

  • Net Cash Used in Operating Activities: ₹(7,097.42) lakhs
  • Net Cash Generated from Investing Activities: ₹6,728.73 lakhs
  • Net Cash Used in Financing Activities: ₹(463.81) lakhs
  • Net Decrease in Cash: ₹(832.50) lakhs
  • Cash and Cash Equivalents at period end: ₹468.17 lakhs

Director Re-appointments

Based on Nomination and Remuneration Committee recommendation, the Board approved:

  • Re-appointment of Mr. P. M. Murty (DIN: 00011179) as Non-Executive Independent Director for second term of three years from April 1, 2027 to March 31, 2030
  • Re-appointment of Ms. Smita Anand (DIN: 00059228) as Non-Executive Independent Director for second term of three years from April 1, 2027 to March 31, 2030

Both appointments are subject to shareholder approval through postal ballot.

Postal Ballot Notice

The Board approved the Postal Ballot Notice to seek shareholder consent for the director re-appointments. The notice and relevant documents will be circulated to members and submitted to stock exchanges in due course.

Meeting Details

Board meeting commenced at 12:15 PM and concluded at 02:50 PM on October 15, 2026.

Additional Information

  • Company operates in one segment: Domestic Appliances
  • No subsidiaries/associates/joint ventures as of September 30, 2026
  • Financial results prepared in accordance with Ind AS
  • Limited review conducted by statutory auditors ASA & Associates LLP (ICAI Firm Registration No. 009571N/N500006)
  • The intimation will be uploaded on company website www.butterflyindia.com and published in newspapers